Environmental Factor – July 2020: DNA repair discovery holds promise for precision cancer therapy

Williams’ lab continues to study APE2, working with other NIEHS researchers to further understand the role and regulation of APE2 in processing ribonucleotides embedded in

READ MORE

New affordable service launched at NHC to accelerate gene therapy development

The National Horizons Centre at Teesside University has launched VecTUs, a new research-grade BioVector production service. VecTUs has been created

READ MORE

Enorama Pharma AB (publ) Explores Divestment of Nicotine Replacement Therapy Chewing Gum Business

The board of directors at Enorama Pharma AB (“Enorama Pharma” or the “Company”) has decided to explore the possibility of

READ MORE

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

JERSEY CITY, N.J., United States:   VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in

READ MORE

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair

Chesterbrook, Pa., United States:   – Breakthrough Therapy designation for NTX-001 granted by FDA – Preparation is underway for the Phase

READ MORE

Pioneering gene therapy trial for Haemophilia A unveiled at CMC Vellore

Marking a turning point in the realm of medical science, India has initiated the first human clinical trial for gene therapy targeting haemophilia A, conducted

READ MORE

Environmental Factor – September 2024: Chelation therapy may reduce blood lead levels, but not heart attacks

Chelation therapy does not reduce the occurrence of major adverse cardiovascular events in patients with diabetes who have had a heart attack, according to a

READ MORE